WallStreetZenWallStreetZen

NASDAQ: ANEB
Anebulo Pharmaceuticals Inc Stock Ownership - Who owns Anebulo Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Anebulo Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Aron R. EnglishDirector2024-12-2310,101,010$0.99
$10.00MBuy

1 of 1

ANEB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANEB insiders and whales buy or sell their stock.

ANEB Shareholders

What type of owners hold Anebulo Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aron R. English48.98%20,121,828$47.69MInsider
22nw LP37.65%15,467,300$36.66MInstitution
Joseph F. Lawler29.21%12,000,000$28.44MInsider
Nantahala Capital Management LLC7.39%3,036,325$7.20MInstitution
Mangrove Partners IM LLC6.15%2,525,252$5.98MInstitution
Morgan Stanley0.97%399,219$946.15kInstitution
Lvw Advisors LLC0.85%349,617$828.59kInstitution
Vanguard Group Inc0.53%215,951$511.80kInstitution
Geode Capital Management LLC0.50%205,720$487.56kInstitution
Ikarian Capital LLC0.38%157,720$373.80kInstitution

1 of 3

ANEB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANEB41.29%58.71%Net Buying
SAVA25.35%72.66%Net Selling
PTHS2.57%97.43%Net BuyingNet Buying
EQ14.64%24.17%Net Selling
ANRO63.88%24.85%
View Top Biotech Stocks

Anebulo Pharmaceuticals Stock Ownership FAQ

Who owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals (NASDAQ: ANEB) is owned by 54.99% institutional shareholders, 78.18% Anebulo Pharmaceuticals insiders, and 0.00% retail investors. Aron R. English is the largest individual Anebulo Pharmaceuticals shareholder, owning 20.12M shares representing 48.98% of the company. Aron R. English's Anebulo Pharmaceuticals shares are currently valued at $49.50M.

If you're new to stock investing, here's how to buy Anebulo Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.